Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Mallia

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
ERJ Open Research|June 29, 2019
Validity of the diagnosis of pneumonia in hospitalised patients with COPDLydia J Finney, Vijay Padmanaban, Samuel Todd, et al.
The Pediatric Infectious Disease Journal|October 23, 2008
Respiratory syncytial virus persistence in chronic obstructive pulmonary diseaseMarkus B Sikkel, Jennifer K Quint, Patrick Mallia, et al.
The Lancet. Respiratory Medicine|September 22, 2014
Inhaled corticosteroids and pneumonia in chronic obstructive pulmonary diseaseLydia Finney, Matthew Berry, Aran Singanayagam, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 13, 2012
Lung microbiology and exacerbations in COPDVictoria Beasley, Priya V Joshi, Aran Singanayagam, et al.
Respiratory Research|September 8, 2006
An experimental model of rhinovirus induced chronic obstructive pulmonary disease exacerbations: a pilot studyPatrick Mallia, Simon D Message, Tatiana Kebadze, et al.
Annals of the American Thoracic Society|November 24, 2015
Pathogenesis of Viral Infection in Exacerbations of Airway DiseaseAndrew I Ritchie, Hugo A Farne, Aran Singanayagam, et al.
Antiviral Research|November 14, 2016
Vitamin D increases the antiviral activity of bronchial epithelial cells in vitroAurica G Telcian, Mihnea T Zdrenghea, Michael R Edwards, et al.
Respiratory Medicine|April 2, 2014
Bronchial platelet-activating factor receptor in chronic obstructive pulmonary diseaseReetika Suri, Patrick Mallia, Joanne E Martin, et al.
Journal of Medical Virology|October 12, 2020
Factors associated with reattendance to emergency services following COVID-19 hospitalizationAnna Daunt, Pablo N Perez-Guzman, John Cafferkey, et al.
Ebiomedicine|July 3, 2015
Rhinovirus-induced VP1-specific Antibodies are Group-specific and Associated With Severity of Respiratory SymptomsKatarzyna Niespodziana, Clarissa R Cabauatan, David J Jackson, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
ERJ Open Research|June 29, 2019
Validity of the diagnosis of pneumonia in hospitalised patients with COPDLydia J Finney, Vijay Padmanaban, Samuel Todd, et al.
The Pediatric Infectious Disease Journal|October 23, 2008
Respiratory syncytial virus persistence in chronic obstructive pulmonary diseaseMarkus B Sikkel, Jennifer K Quint, Patrick Mallia, et al.
The Lancet. Respiratory Medicine|September 22, 2014
Inhaled corticosteroids and pneumonia in chronic obstructive pulmonary diseaseLydia Finney, Matthew Berry, Aran Singanayagam, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 13, 2012
Lung microbiology and exacerbations in COPDVictoria Beasley, Priya V Joshi, Aran Singanayagam, et al.
Respiratory Research|September 8, 2006
An experimental model of rhinovirus induced chronic obstructive pulmonary disease exacerbations: a pilot studyPatrick Mallia, Simon D Message, Tatiana Kebadze, et al.
Annals of the American Thoracic Society|November 24, 2015
Pathogenesis of Viral Infection in Exacerbations of Airway DiseaseAndrew I Ritchie, Hugo A Farne, Aran Singanayagam, et al.
Antiviral Research|November 14, 2016
Vitamin D increases the antiviral activity of bronchial epithelial cells in vitroAurica G Telcian, Mihnea T Zdrenghea, Michael R Edwards, et al.
Respiratory Medicine|April 2, 2014
Bronchial platelet-activating factor receptor in chronic obstructive pulmonary diseaseReetika Suri, Patrick Mallia, Joanne E Martin, et al.
Journal of Medical Virology|October 12, 2020
Factors associated with reattendance to emergency services following COVID-19 hospitalizationAnna Daunt, Pablo N Perez-Guzman, John Cafferkey, et al.
Ebiomedicine|July 3, 2015
Rhinovirus-induced VP1-specific Antibodies are Group-specific and Associated With Severity of Respiratory SymptomsKatarzyna Niespodziana, Clarissa R Cabauatan, David J Jackson, et al.
Pageof 9